Free Trial

Merck KGaA (MKGAF) News Today

Merck KGaA logo
$128.78 -3.02 (-2.29%)
As of 12:50 PM Eastern

MKGAF Latest News

Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Should You Buy?
Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript
Merck KGaA (OTCMKTS:MKGAF) Short Interest Update
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 49%?
Merck Q1 Earnings Preview: What to expect?
SpringWorks gets FDA approval for mirdametinib
SpringWorks jumps as Merck KGaA reportedly in talks to acquire company
Merck announces $10B share repurchase authorization
Kepler Capital Keeps Their Buy Rating on Merck KGaA (0O14)
Get Merck KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter.

MKGAF Media Mentions By Week

MKGAF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MKGAF
News Sentiment

0.86

0.57

Average
Medical
News Sentiment

MKGAF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MKGAF Articles
This Week

3

1

MKGAF Articles
Average Week

Get Merck KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:MKGAF) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners